Federated Hermes’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6
| Closed | -$9 | – | 2148 |
|
|
2024
Q3 | $9 | Buy |
6
+5
| +500% | +$8 | ﹤0.01% | 2049 |
|
|
2024
Q2 | $2 | Buy |
+1
| New | +$2 | ﹤0.01% | 2017 |
|
|
2023
Q4 | – | Sell |
-16,493
| Closed | -$18K | – | 2129 |
|
|
2023
Q3 | $18K | Buy |
16,493
+6,925
| +72% | +$7.55K | ﹤0.01% | 1776 |
|
|
2023
Q2 | $21.9K | Buy |
+9,568
| New | +$21.9K | ﹤0.01% | 1762 |
|
|
2021
Q3 | – | Sell |
-21,505
| Closed | -$99K | – | 2281 |
|
|
2021
Q2 | $99K | Buy |
21,505
+2,083
| +11% | +$9.59K | ﹤0.01% | 1794 |
|
|
2021
Q1 | $114K | Sell |
19,422
-11,548
| -37% | -$67.8K | ﹤0.01% | 1772 |
|
|
2020
Q4 | $106K | Sell |
30,970
-1,678,806
| -98% | -$5.75M | ﹤0.01% | 1747 |
|
|
2020
Q3 | $2.46M | Hold |
1,709,776
| – | – | 0.01% | 913 |
|
|
2020
Q2 | $3.41M | Buy |
1,709,776
+992,069
| +138% | +$1.98M | 0.01% | 812 |
|
|
2020
Q1 | $1.4M | Buy |
717,707
+605,310
| +539% | +$1.18M | ﹤0.01% | 1005 |
|
|
2019
Q4 | $466K | Buy |
112,397
+112,326
| +158,206% | +$466K | ﹤0.01% | 1465 |
|
|
2019
Q3 | $1K | Sell |
71
-9,791
| -99% | -$138K | ﹤0.01% | 2114 |
|
|
2019
Q2 | $62K | Sell |
9,862
-2,749
| -22% | -$17.3K | ﹤0.01% | 1648 |
|
|
2019
Q1 | $70K | Buy |
12,611
+11,721
| +1,317% | +$65.1K | ﹤0.01% | 1625 |
|
|
2018
Q4 | $6K | Buy |
+890
| New | +$6K | ﹤0.01% | 1951 |
|
|
2016
Q4 | – | Sell |
-4,294
| Closed | -$78K | – | 2139 |
|
|
2016
Q3 | $78K | Buy |
+4,294
| New | +$78K | ﹤0.01% | 1583 |
|